DCF — ALLE-KISKI MEDICAL CENTER
Enterprise Value: $-96.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-96.4M
Enterprise Value
$-32.3M
PV of Cash Flows
$-64.2M
PV of Terminal Value
$-103.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $112.3M | $-5.1M | -5.0% | $-9.8M | $-8.9M |
| Year 2 | $115.7M | $-4.0M | -4.0% | $-8.9M | $-7.4M |
| Year 3 | $119.1M | $-3.0M | -3.0% | $-8.0M | $-6.0M |
| Year 4 | $122.7M | $-2.5M | -2.0% | $-7.6M | $-5.2M |
| Year 5 | $126.4M | $-2.2M | -2.0% | $-7.6M | $-4.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-96.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$109.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000004127502364
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5